Viewing Study NCT03524261


Ignite Creation Date: 2025-12-24 @ 12:16 PM
Ignite Modification Date: 2025-12-27 @ 9:30 PM
Study NCT ID: NCT03524261
Status: WITHDRAWN
Last Update Posted: 2020-10-19
First Post: 2018-05-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer
Sponsor: Fuda Cancer Hospital, Guangzhou
Organization:

Study Overview

Official Title: Phase II Randomized Comparison Clinical Trial of Target Activated CIK for Advanced Breast Cancer
Status: WITHDRAWN
Status Verified Date: 2020-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: No participants enrolled
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a phase II Randomized comparison clinical trial of activated CIK armed with anti-CD3-MUC1 bispecific antibody for advanced breast cancer. And the aim of this research is to study the clinical efficacy and safety of activated CIK armed with anti-CD3-MUC1 bispecific antibody for breast cancer.
Detailed Description: Primary breast carcinoma is one of the most common malignancies in China, ranking first in all malignant tumors of women.immunotherapy is considered to be one of the most promising means of human against cancer. This is a phase II clinical trial of single- center, The investigators plan to recruit for 90 patients with advanced breast cancer,and all patients are divided into three groups.one group will receive cryotherapy, one group will receive conventional therapy,and the rest one will receive mixed liquor of activated CIK and anti-CD3-MUC1 bispecific antibody together with cryotherapy.

The result of this study was statistic and analysed with the record of Response Evaluation Criteria In Solid Tumors(RECIST1.1) evaluation standard.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: